Pfizer raises full-year outlook on covid-19 vaccine sales
Premium
2 min read . Updated: 28 Jul 2021, 05:43 PM IST - The pharmaceutical giant’s quarterly revenue nearly doubled year over year
Premium 2 min read . Updated: 28 Jul 2021, 05:43 PM IST Pfizer Inc. raised its full-year forecast for sales of its Covid-19 vaccine to about $33.5 billion, a nearly 30% increase, helping lift the pharmaceutical giant’s overall estimates for its sales and profits in 2021.
